InsidersTradesSigma
Follow the Yarrow Bioscience, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €98.8m. The latest transaction was reported on 30 July 2026 (J). Among the most active insiders: RTW Fund Group GP, LLC. Every trade is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Yarrow Bioscience, Inc. is a company listed on the XNAS market, specializing in the development of biopharmaceutical solutions. It focuses on innovation in the life sciences sector.